Labquality, supported by
Mérieux Equity Partners, acquires QAdvis AB.Labquality Corporation
acquires Swedish QAdvis AB, which specializes in quality management and
regulatory affairs services for medical device and in vitro diagnostic
device manufacturers. They have a strong position in the Swedish quality and
regulatory affairs services market. QAdvis also has broad experience and
know-how in medical device software, from risk management and validation to
quality assurance. The acquisition aligns with Labquality’s international
growth strategy and enables Labquality to enter and grow its business in
Sweden.The acquisition enables
Labquality to expand market coverage in the Nordics further. “QAdvis fits
perfectly into our Labquality family, complementing our regulatory affairs and
quality management business. In fact, the acquisition will significantly grow
our regulatory affairs services offering. Particularly, their experience and
competence in medical device software will further strengthen our position in
the digital health market. Additionally, QAdvis is well connected to national
and EU regulatory bodies and committees”, says CEO Juha-Pekka Nuutinen from
Labquality.“With Labquality, we form
an excellent platform for our teams to further grow and support the medical
device industry. We are convinced that this platform will be very valuable for
our combined client bases. Labquality has an established and highly valued
regulatory affairs expertise and a clear strategy to take its business to the
next level. Becoming a part of Labquality enables us to combine better and
leverage our quality and regulatory affairs services to the Nordic and
international markets. We look forward to working within the Labquality team”,
concludes Robert Ginsberg, the CEO of QAdvis.The acquisition strengthens
Labquality’s position as an expert services provider for the health technology
industry.The acquisition does not
impact the current customer relationships, partnerships, or personnel of QAdvis
or Labquality.For queries, please
contact:
Juha-Pekka Nuutinen
CEO | Labquality
+358 40 828 3210 | jp.nuutinen(a)labquality.comRobert Ginsberg
CEO | QAdvis
+46 760 199 469 | robert.ginsberg(a)qadvis.comLabqualityWe create quality excellence in healthcare on every continent. That’s our
vision.We are quality makers – a team of experienced experts in healthcare and
health-tech quality. Our quality services for the healthcare, pharmaceutical
and medical technology industries cover external quality assessments,
regulatory consulting, clinical investigations and trials, audits and
certifications, and training. Our expertise and knowledge benefit medical
device and in vitro diagnostic manufacturers, pharmaceutical companies,
healthcare units, and clinical laboratories.Currently, we serve customers in over 60 countries. Our team comprises 150
skilled professionals, and our offices are in Finland, Poland, and Germany.For more information, please visit www.labquality.com.Mérieux Equity
PartnersFounded in 2009, Mérieux Equity Partners (“MxEP”) is a leading European
healthcare-specialized investment firm, with two dedicated platforms, Venture
Capital and Buyout, supporting companies ranging from start-ups to established
leaders. Benefiting from a longstanding expertise and a large network, MxEP
invests in companies with ambitious growth projects and products or services
transformative for Health. MxEP is AMF-accredited and currently manages
c.€1.5bn of AuM. Labquality has been supported by Mérieux Equity Partners since
November 2023.For more information, please visit www.merieux-partners.com. QAdvisWe simplify regulatory complexity to accelerate successful market
availability of safe and effective medical devices for the improvement of
health and human lives across the globe.We have long experience and international backgrounds from the medical
device industry, academia, Notified Body and Competent Authority. We
participate in international medical device standard committees and are
stakeholder representatives in Eu Commission MDCG working groups.Our services include quality management, regulatory affairs, clinical
evidence, risk management, software, interim management, strategic advice, due
diligence, auditing, training, etc. QAdvis mainly targets the Nordics but have
clients all over the world. QAdvis provides Authorized Representation services
in the EU and UK through separate QAdvis companies in Sweden and the
UK. For more information, please visit www.qadvis.com.
